Volume 26, Issue 6

Search all Gastric Cancer articles

November 2023

20 articles in this issue

The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-analysis
Elzbieta Budginaite
Maximilian Kloft
Heike I. Grabsch
Review Article Open access 30 September 2023 Pages: 847 - 862
Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model
Huiying Li
Cuicui Jia
Hongpeng Jiang
Original Article 21 June 2023 Pages: 863 - 877
Down-regulation of stimulator of interferon genes (STING) expression and CD8⁺ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer
Satoshi Fukai
Shotaro Nakajima
Koji Kono
Original Article 05 August 2023 Pages: 878 - 890
Collagen-related gene expression level predicts the prognosis and immune therapy response
Jianchao Wang
Zhentian Liu
Gang Chen
Original Article 06 August 2023 Pages: 891 - 903
PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment
Yi Liu
Daoyan Wei
Xiangsheng Zuo
Original Article Open access 12 August 2023 Pages: 904 - 917
CD45⁻ erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells
Jing-Yun Wen
Xing Li
Chun-Kui Shao
Original Article 07 September 2023 Pages: 918 - 933
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients
Mihaela Chivu-Economescu
Vlad Herlea
Dan G. Duda
Original Article 05 September 2023 Pages: 934 - 946
LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer
Zhe-bin Dong
Han-ting Xiang
Chao Liang
Original Article Open access 10 September 2023 Pages: 947 - 957
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action
Lorenzo Fornaro
Sara Lonardi
Matteo Fassan
Original Article 29 June 2023 Pages: 958 - 968
Circulating hormones and risk of gastric cancer by subsite in three cohort studies
Harinakshi Sanikini
Carine Biessy
Amanda J. Cross
Original Article Open access 16 July 2023 Pages: 969 - 987
Metachronous primary gastric cancer after endoscopic resection in patients with esophageal squamous cell carcinoma
Motohiro Hirao
Chikatoshi Katada
Manabu Muto
Original Article 27 June 2023 Pages: 988 - 1001
Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylori-naïve patients
Kotaro Shibagaki
Norihisa Ishimura
Shunji Ishihara
Original Article 06 August 2023 Pages: 1002 - 1011
Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study
Tae-Hwan Kim
Jin-Hyuk Choi
Seung-Soo Sheen
Original Article 30 August 2023 Pages: 1012 - 1019
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Ryohei Kawabata
Keisho Chin
Kensei Yamaguchi
Original Article Open access 23 August 2023 Pages: 1020 - 1029
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience
Mashiro Okunaka
Akihito Kawazoe
Kohei Shitara
Original Article 04 September 2023 Pages: 1030 - 1039
SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis
Xingmao Huang
Jingquan Fang
Pengfei Yu
Original Article Open access 28 September 2023 Pages: 1040 - 1050
Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-center study
Hua Xiao
Yongzhou Huang
Jia Luo
Original Article Open access 14 August 2023 Pages: 1051 - 1062
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study
Yasuhiro Kodera
Kazuhiro Yoshida
Masashi Fujii
Short Communication Open access 07 August 2023 Pages: 1063 - 1068
Numerous lesions of gastric adenocarcinoma of fundic-gland and fundic gland-mucosa type in a patient
Kentaro Imamura
Kenshi Yao
Masaki Miyaoka
Case Report 11 August 2023 Pages: 1069 - 1073
Acknowledgment to Reviewers

Acknowledgment to Reviewers 08 November 2023 Pages: 1074 - 1075

Volume 26, Issue 6

The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-analysis

Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model

Down-regulation of stimulator of interferon genes (STING) expression and CD8⁺ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer

Collagen-related gene expression level predicts the prognosis and immune therapy response

PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment

CD45⁻ erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells

Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients

LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer

Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action

Circulating hormones and risk of gastric cancer by subsite in three cohort studies

Metachronous primary gastric cancer after endoscopic resection in patients with esophageal squamous cell carcinoma

Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylori-naïve patients

Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study

Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience

SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis

Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-center study

Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study

Numerous lesions of gastric adenocarcinoma of fundic-gland and fundic gland-mucosa type in a patient

Acknowledgment to Reviewers

Navigation